Literature DB >> 1468777

Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue.

E Campo1, M J Merino, L Liotta, R Neumann, W Stetler-Stevenson.   

Abstract

The 72-kd type IV collagenase (matrix metalloproteinase-2 [MMP-2]) is a neutral metalloproteinase that initiates the degradation of type IV collagen in basement membranes. Its production by tumor cells has been correlated with the invasive and metastatic potential of neoplasms. Two recently developed affinity-purified antibodies against synthetic peptides from the amino terminus (H1) and an internal domain (Ab48) of the molecule were used to investigate immunohistochemically the distribution of this enzyme in a variety of thyroid tissues. All primary carcinomas (20 papillary, seven follicular, and three medullary) as well as nine of 11 metastases were positive, with the more aggressive tumors (tall cell variant of papillary carcinomas and invasive follicular carcinomas) tending to be more reactive than the low-grade tumors (classic and microinvasive papillary carcinomas and minimally invasive follicular tumors). Negative or minimal positivity was found in six cases of normal thyroid, one goiter, and two cases of Graves' disease. Immunoreactive follicular cells were seen focally in areas of inflammation, fibrosis, and distortion of normal follicles, and in Hashimoto's thyroiditis (four cases). Five of nine adenomas showed positive cells, but this could be related to previous trauma to the area. We conclude that there is increased production of the 72-kd type IV collagenase (MMP-2) in thyroid cancer; however, this enzyme also is elevated in benign conditions that are undergoing remodeling and repair.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468777     DOI: 10.1016/0046-8177(92)90060-g

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Effect of TTC Treatment on Immunohistochemical Quantification of Collagen IV in Rat Brains after Stroke.

Authors:  Zhaojin Li; Nicole Bishop; Siu-Lung Chan; Marilyn J Cipolla
Journal:  Transl Stroke Res       Date:  2018-01-08       Impact factor: 6.829

Review 2.  Papillary carcinoma tall cell variant (TCV): a review.

Authors:  Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

3.  Type IV collagenase in squamous cell and basal cell skin carcinomas.

Authors:  N Slade; J Pavelić; B Kurslin; K Pavelić
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension.

Authors:  Michael Rivera; Julio Ricarte-Filho; Robert Michael Tuttle; Ian Ganly; Ashok Shaha; Jeffrey Knauf; James Fagin; Ronald Ghossein
Journal:  Thyroid       Date:  2010-10       Impact factor: 6.568

5.  Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.

Authors:  Luc G T Morris; Ashok R Shaha; R Michael Tuttle; Andrew G Sikora; Ian Ganly
Journal:  Thyroid       Date:  2010-02       Impact factor: 6.568

6.  Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples.

Authors:  M R Emmert-Buck; M J Roth; Z Zhuang; E Campo; J Rozhin; B F Sloane; L A Liotta; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2.

Authors:  Paola Catanuto; Jun Tashiro; Ferenc G Rick; Patricia Sanchez; Carmen C Solorzano; Marilyn K Glassberg; Norman L Block; John I Lew; Sharon J Elliot; Andrew V Schally
Journal:  Horm Cancer       Date:  2015-03-10       Impact factor: 3.869

8.  Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy.

Authors:  M Polette; N Gilbert; I Stas; B Nawrocki; A Nöel; A Remacle; W G Stetler-Stevenson; P Birembaut; M Foidart
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Thyroid Peroxidase Expression in Diseased Human Thyroid Glands.

Authors:  Marcus A. Lima; Valeria A. Gontijo; Marlene C. Santos; Fernando C. L. Schmitt
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

10.  Thyroid Peroxidase and Thyroglobulin Expression in Normal Human Thyroid Glands.

Authors:  Marcus A. Lima; Vakria A. Gontijo; Fernando C. L. Schmitt
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.